Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ryan David Lake currently holds 336,691 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan David Lake has been a net buyer of REPH stock. They have purchased $2.0K and sold $0 worth of shares.
Ryan David Lake's most recent insider trade was on Sep 3, 2025, when they sold 22,932 shares at $7.71 per share.
Ryan David Lake serves as Executive at Recro Pharma, Inc. (REPH). They have executed 91 insider transactions totaling $2.0K over their tenure at the company.
Ryan David Lake holds the position of Executive at Recro Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Ryan David Lake has shown a buying trading pattern, with $2.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ryan David Lake was on Apr 8, 2024, when they sold $1.2M worth of SCTL shares. This transaction involved 1,049,287 shares at $1.10 per share.
Ryan David Lake currently owns 336,691 shares of Recro Pharma, Inc. (REPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ryan David Lake's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ryan David Lake has 91 Form 4 filings on record as an insider at Recro Pharma, Inc..
Set alerts for Ryan David Lake and 40,000+ other insiders.